Categories

Archives

Risk Analysis in the Crosshairs: Four Recent Ransomware Resolutions Preview the HIPAA Security Rule Amendments

On April 23, 2026, the U.S. Department of Health and Human Services’ (HHS) Office for Civil Rights (OCR) announced resolution agreements and corrective action plans with four regulated entities following separate ransomware investigations under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Security Rule. The settlements are the culmination of OCR investigations into separate ransomware breaches collectively affecting more than 427,000 individuals and involving the exposure of unsecured electronic protected health information (ePHI) – demographic data, Social Security numbers, financial information, lab results, medications, and diagnoses or conditions. Under the settlements, the regulated entities agreed to implement corrective action plans subject to OCR monitoring for two years and pay a total resolution amount of $1,165,000 to OCR.

New York Department of Financial Services Issues Coordinated Guidance on Frontier AI Cybersecurity Risks

On May 21, 2026, the New York State Department of Financial Services (“DFS”) issued two coordinated Industry Letters: a letter on Heightened Cybersecurity Risks Associated with Frontier AI Models (the “AI Advisory”) and accompanying Guidance on Measures Regulated Entities Should Consider in a Heightened Cybersecurity Threat Environment (the “Guidance,” and together, the “May 2026 Publications”). The AI Advisory builds on DFS’s October 2024 guidance on cybersecurity risks arising from AI, but is narrower in focus. Specifically, it addresses frontier models that may materially increase the speed and effectiveness of vulnerability discovery and exploitation.

(more…)

Chambers 2026 Global Practice Guide for Artificial Intelligence

The Chambers 2026 Global Practice Guide for Artificial Intelligence provides the latest legal information on the rapidly evolving AI landscape, covering the commercial use of AI across key industries, AI-specific legislation and regulation, government and regulatory oversight, generative AI, agentic AI systems and autonomous decision-making, liability, procurement and supply chain accountability, employment, IP, data protection, antitrust, cybersecurity, ESG, and AI governance and compliance.

(more…)

Scientific Research and the GDPR: EDPB Issues Long-Awaited Guidelines

On 15 April 2026, the European Data Protection Board (“EDPB”) published its long-awaited draft Guidelines 1/2026 on the processing of personal data for scientific research purposes (the “Guidelines”), marking the most comprehensive regulatory statement to date on how the GDPR applies to scientific research activities.

(more…)

Preparing for the UK’s New Data Protection Complaints Regime: Key Steps Before June 2026

The Data (Use and Access) Act 2025 (“DUAA”) has made a number of changes to the UK’s data protection regime, many of which have already come into force. From 19 June 2026, organisations will need to implement or update their data protection complaints procedure to align with the new DUAA requirements which provide a mechanism for complaints made directly to a controller. This new requirement is supported by recent guidance from the UK Information Commissioner’s Office (“ICO”). This marks a shift towards a more formalised, controller-led complaints-handling framework, requiring organisations to treat certain expressions of dissatisfaction as regulated complaints with defined procedural obligations.

U.S. SEC Regulation S-P: Compliance Deadline Approaching for Smaller Entities

The U.S. Securities and Exchange Commission has issued amendments to Regulation S-P: Privacy of Consumer Financial Information and Safeguarding Customer Information, which became effective on August 2, 2024 (the Final Amendments). For smaller entities, including registered investment advisers with less than $1.5 billion in assets under management, as well as certain broker-dealers and other SEC-regulated entities, the compliance deadline is June 3, 2026. The compliance deadline for larger entities was December 3, 2025. For a full list of entities required to comply, please see June 4, 2024 Sidley Update.

(more…)

European Biotech Act I: Navigating the EDPB/EDPS Vision for the Future of Clinical Trials

On 12 March 2026, the European Data Protection Board (“EDPB”) and the European Data Protection Supervisor (“EDPS”) issued a Joint Opinion (the “Joint Opinion”) on the proposed European Biotech Act I (the “Biotech Act”). The Joint Opinion broadly supports the EU’s ambition to strengthen its biotechnology sector. However, it emphasises that data protection safeguards must be tightened, particularly where health data is involved. The recommendations signal forthcoming scrutiny during the legislative process and highlight key compliance considerations for organisations involved in clinical trials.

(more…)

U.S. SEC Clears Path for Decentralized Crypto Asset Security Trading With Broker Registration Exception for User Interfaces

On April 13, 2026, the staff of the Division of Trading and Markets (Staff) of the U.S. Securities and Exchange Commission (SEC or the Commission) issued a statement (Statement) that it would not object to certain technology providers — referred to as “Covered User Interface Providers” — creating, offering, and/or operating software interfaces that allow users to prepare and submit transactions in crypto asset securities without registering as broker-dealers.

(more…)

Upcoming Events

Resources

 

SUBSCRIBE

To receive email alerts when we post a blog entry, please provide your name and email address.